ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +13.6% ·
aandelenstroom +1.9% ·
netto nieuwe posities +8.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 91.62K | $4.55M | n/a | n/a |
| Q2 2026 | 156 | +1 | 159.53M | $13.74B | +8 | −8 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | n/a |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | n/a | −2 |
| Q2 2024 | 18 | n/a | 44.34M | $4.81B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 23.29M | +0.2% | $2.29B | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | Dodge & Cox ✦ | 23.22M | +5.1% | $2.29B | 1.2% | ▲ Add | 6 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 16.15M | +0.2% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 4 | T. Rowe Price ✦ | 15.08M | +1.9% | $1.49B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passief) | 8.63M | -1.3% | $852.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 5.20M | +1.4% | $509.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Harris Associates (Oakmark) ✦ | 4.75M | +27.3% | $467.93M | 0.8% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | PRIMECAP Management ✦ | 4.25M | -9.8% | $418.69M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 1.78M | n/a | $175.20M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 10 | Morgan Stanley ✦ | 1.69M | n/a | $166.79M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | AQR Capital Management ✦ | 929.90K | -28.5% | $91.60M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 12 | Goldman Sachs Group ✦ | 818.94K | n/a | $80.67M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 473.61K | -8.0% | $46.65M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Marshall Wace ✦ | 301.97K | +21.0% | $29.74M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 15 | GAMCO Investors ✦ | 239.84K | -2.5% | $23.62M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 143.03K | +18.8% | $14.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Millennium Management ✦ | 137.05K | +1031.8% | $13.50M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 121.80K | Nieuw | $12.00M | 0.0% | New | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 116.15K | Nieuw | $11.44M | 0.0% | New | 1 | SEC ↗ ×2 |
| 20 | Wellington Management ✦ | 40.23K | +6.0% | $3.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 21 | Gotham Asset Management ✦ | 39.38K | -55.7% | $3.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 12.55K | +91.3% | $1.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Capital World Investors ✦ | 4.98K | +61.4% | $490,235 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 4.39K | -2.1% | $433,003 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 3.39K | Nieuw | $334,211 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $12.00M | 0.0% |
| Citadel Advisors | $11.44M | 0.0% |
| Two Sigma Investments | $334,211 | 0.0% |
Verlaten
| Norges Bank | $225.87M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 908 houders, 191.49M aandelen, $15.84B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 5.69K aand · $528,978
Officer · 3.00K aand · $295,050
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie